Recent genetic exploration of these biomarker groups suggests the frequency of the APOE ε4 genotype (a genetic susceptibility risk factor for AD) may be lower in SNAP when compared to amyloid positive or amyloid positive/neurodegeneration positive groups [4]. The gene discussed is APOE; the disease is Alzheimer disease.